Company intelligence / Profile preview

Aeon Biomarkers

Ownership: Private
Development stage: Preclinical

Overview

Aeon Biomarkers provides advanced analysis of hundreds of dynamic biomarkers to identify precise indicators of biological aging. Their service enables healthcare businesses to gain insights into the biology of aging, supporting early detection, prevention strategies, and personalized interventions. They claim to have created one of the most comprehensive datasets in this field but do not report clinical trial results as they are not developing therapeutics.

Therapeutic areas: Other
Modalities: Biomarker discovery and analysis (focus on dynamic biomarkers of aging)Data analytics for biological age assessmentEpigenetic profiling
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Aeon Biomarkers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aeon Biomarkers.

Explore the full profile